Warshaw M L, Johnson D C, Khan I, Eckstein B, Gibori G
Endocrinology. 1986 Dec;119(6):2642-8. doi: 10.1210/endo-119-6-2642.
In contrast to the human placenta, which does not secrete androgens, the rat placenta synthesizes significant amounts of these steroids. The purpose of this study was to determine why the rat placenta does not secrete androgens before day 12 of pregnancy, to ascertain whether the rat placenta secretes more androstenedione than testosterone, to compare the capacity of luteal and placental tissue to secrete androgen, and to determine whether the rat placental produces androstenedione via the delta 4- or delta 5-steroidogenic pathway. To determine whether the inability of the rat placenta to produce androstenedione before midpregnancy was due to the absence of active 17 alpha-hydroxylase and 17,20-lyase enzymes and also to investigate the ontogeny of both placental production of androstenedione and enzyme activities, placentas were isolated from rats between days 8-21 of pregnancy and either incubated or used to determine the activities of 17 alpha-hydroxylase and 17,20-lyase. Before day 11, enzyme activity was not detectable. From day 11, both enzyme activities and placental secretion of androstenedione steadily increased to peak values by day 18 and declined just before parturition. To investigate the principal aromatizable androgen secreted both in vivo and in vitro approaches were used. Levels of androstenedione and testosterone found in the uterine vein as well as those produced by placental tissue were determined. Rat placentas secreted markedly more androstenedione than testosterone, both in vivo and in vitro. When placental and luteal secretion of androstenedione and testosterone were compared, it was found that luteal tissue had a higher capacity for androgen synthesis than did the placenta. Yet, because of its greater mass, each placenta secreted 15 times more androstenedione and 4.5 times more testosterone than each corpus luteum. To determine the preferential usage of progesterone or pregnenolone as substrate by the placenta, [14C] progesterone and [3H]pregnenolone were added in equimolar concentrations. The resulting 14C to 3H ratio of the androgen produced indicates that the preferred substrate is progesterone. In summary, results of this investigation describe, for the first time, the development of 17 alpha-hydroxylase and 17,20-lyase activities in the rat placenta and demonstrate that the placenta does not produce androgen before day 11 due to the absence of active enzymes. The results further demonstrate that the rat placenta secretes significantly more androstenedione that testosterone both in vivo and in vitro, produces more androgen than the corpus luteum because of its greater mass, and forms its androgen primarily via the delta 4-st
与不分泌雄激素的人类胎盘不同,大鼠胎盘能合成大量此类类固醇。本研究的目的是确定大鼠胎盘在妊娠第12天之前不分泌雄激素的原因,确定大鼠胎盘分泌的雄烯二酮是否比睾酮多,比较黄体组织和胎盘组织分泌雄激素的能力,并确定大鼠胎盘是通过Δ4-还是Δ5-类固醇生成途径产生雄烯二酮。为了确定大鼠胎盘在妊娠中期之前无法产生雄烯二酮是否是由于缺乏活性17α-羟化酶和17,20-裂解酶,同时也为了研究胎盘产生雄烯二酮和酶活性的个体发生情况,从妊娠第8至21天的大鼠中分离出胎盘,要么进行孵育,要么用于测定17α-羟化酶和17,20-裂解酶的活性。在第11天之前,无法检测到酶活性。从第11天开始,酶活性和胎盘雄烯二酮的分泌量稳步增加,到第18天达到峰值,在分娩前下降。为了研究体内和体外分泌的主要可芳香化雄激素,采用了体内和体外方法。测定了子宫静脉中发现的雄烯二酮和睾酮水平以及胎盘组织产生的水平。无论是在体内还是体外,大鼠胎盘分泌的雄烯二酮都明显多于睾酮。当比较胎盘和黄体分泌雄烯二酮和睾酮的情况时,发现黄体组织的雄激素合成能力比胎盘高。然而,由于胎盘质量更大,每个胎盘分泌的雄烯二酮比每个黄体多15倍,分泌的睾酮比每个黄体多4.5倍。为了确定胎盘优先使用孕酮还是孕烯醇酮作为底物,以等摩尔浓度加入[14C]孕酮和[3H]孕烯醇酮。所产生的雄激素的14C与3H的比率表明,首选底物是孕酮。总之,本研究结果首次描述了大鼠胎盘17α-羟化酶和17,20-裂解酶活性的发育情况,并表明由于缺乏活性酶,胎盘在第11天之前不产生雄激素。结果还进一步表明,大鼠胎盘在体内和体外分泌的雄烯二酮都明显多于睾酮,由于其质量更大,产生的雄激素比黄体多,并且其雄激素主要通过Δ4-途径形成。